Market Currents
CVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement....
-
Thursday, July 19, 2012, 10:35 AM ETCVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement. The drugstore operator adds $0.05 to its overall FY12 estimate of extra business from the WAG-ESRX dispute after factoring in that it will retain 50% of the customers it gained from Walgreen through Q4.
Other date
Latest Articles
